Novo Nordisk hired Thermo Fisher Scientific as a second manufacturer as demand for its weight-loss drug Wegovy (semaglutide) soars and amid Catalent’s production problems at a factory in Brussels, Belgium. According to Reuters, Thermo Fisher is filling Wegovy injection pens at its factory in Greenville, NC through its CDMO subsidiary Patheon. In May, Reuters reported that Novo had brought on a second, then-unnamed manufacturer. The news comes in the wake of reports of difficulties with Cat...